CHINA PHARMA HOLDINGS, INC. Operating Lease Cost
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Operating Lease Cost of $17.99 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-05-15
- CHINA PHARMA HOLDINGS, INC. operating lease, cost for the quarter ending 2026-03-31 was $17.99K, a 6.21% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. operating lease, cost for the quarter ending 2025-12-31 was $18.80K.
- CHINA PHARMA HOLDINGS, INC. operating lease, cost for the quarter ending 2025-09-30 was $18.26K, a 10.04% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. operating lease, cost for the quarter ending 2025-06-30 was $19.29K, a 0.33% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. operating lease, cost for fiscal 2025 was $75.53K, a 28.17% increase from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. operating lease, cost for fiscal 2024 was $58.93K, a 203.56% increase from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. operating lease, cost for fiscal 2023 was $19.41K, a 75.14% decline from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. operating lease, cost for fiscal 2022 was $78.09K, a 15.20% decline from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 9 month as first filed | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $17.99K 10-Q · filed 2026-05-15 | $36.79K derived: sum of 2 quarters · filed 2026-05-15 | $55.05K derived: sum of 3 quarters · filed 2026-05-15 | $74.34K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-12-31 | $18.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $37.07K derived: sum of 2 quarters · filed 2026-04-01 | $56.36K derived: sum of 3 quarters · filed 2026-04-01 | $75.53K 10-K · filed 2026-04-01 | |||
| 2025-09-30 | $18.26K 10-Q · filed 2025-11-12 | $37.55K derived: sum of 2 quarters · filed 2025-11-12 | $56.73K 10-Q · filed 2025-11-12 | $56.73K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-06-30 | $19.29K 10-Q · filed 2025-08-14 | $38.47K 10-Q · filed 2025-08-14 | $38.47K derived: sum of 3 quarters · filed 2026-05-15 | $58.77K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-03-31 | $19.18K 10-Q · filed 2026-05-15 | $19.18K derived: sum of 2 quarters · filed 2026-05-15 | $39.48K derived: sum of 3 quarters · filed 2026-05-15 | $58.71K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $20.30K derived: sum of 2 quarters · filed 2026-04-01 | $39.53K derived: sum of 3 quarters · filed 2026-04-01 | $58.93K 10-K · filed 2026-04-01 | $76.60K 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $20.30K 10-Q · filed 2025-11-12 | $39.53K derived: sum of 2 quarters · filed 2025-11-12 | $58.93K 10-Q · filed 2025-11-12 | $21.31K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $19.23K 10-Q · filed 2025-08-14 | $38.63K 10-Q · filed 2025-08-14 | $1.01K derived: sum of 3 quarters · filed 2025-08-14 | $20.42K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $19.41K 10-Q · filed 2025-05-14 | -$18.22K derived: sum of 2 quarters · filed 2025-05-14 | $1.19K derived: sum of 3 quarters · filed 2025-05-14 | $19.04K derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | -$37.63K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$18.22K derived: sum of 2 quarters · filed 2025-03-31 | -$374.00 derived: sum of 3 quarters · filed 2025-03-31 | $19.41K 10-K · filed 2025-03-31 | $77.27K 10-K · filed 2024-04-01 | ||
| 2023-09-30 | $19.41K 10-Q · filed 2024-11-13 | $37.26K derived: sum of 2 quarters · filed 2024-11-13 | $57.05K 10-Q · filed 2024-11-13 | $94.62K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $17.85K 10-Q · filed 2024-08-14 | $37.63K 10-Q · filed 2024-08-14 | $75.21K derived: sum of 3 quarters · filed 2024-08-14 | $94.31K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $19.79K 10-Q · filed 2023-05-12 | $57.36K derived: sum of 2 quarters · filed 2024-04-01 | $76.46K derived: sum of 3 quarters · filed 2024-04-01 | $95.56K derived: sum of 4 quarters · filed 2024-04-01 | |||
| 2022-12-31 | $37.57K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $56.67K derived: sum of 2 quarters · filed 2024-04-01 | $75.78K derived: sum of 3 quarters · filed 2024-04-01 | $78.09K 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $19.10K 10-Q · filed 2023-11-13 | $16.93K 10-Q · filed 2022-11-14 | $38.20K derived: sum of 2 quarters · filed 2023-11-13 | $40.52K 10-Q · filed 2023-11-13 | $57.45K 10-Q · filed 2022-11-14 | $81.53K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $19.10K 10-Q · filed 2023-08-14 | $40.52K 10-Q · filed 2023-08-14 | $62.43K derived: sum of 3 quarters · filed 2023-08-14 | $84.62K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $22.20K 10-Q · filed 2023-05-12 | $21.42K 10-Q · filed 2022-05-12 | $43.33K derived: sum of 2 quarters · filed 2023-05-12 | $65.52K derived: sum of 3 quarters · filed 2023-05-12 | $90.31K derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $21.13K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $43.33K derived: sum of 2 quarters · filed 2023-03-30 | $68.12K derived: sum of 3 quarters · filed 2023-03-30 | $92.08K 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $22.20K 10-Q · filed 2022-11-14 | $46.99K derived: sum of 2 quarters · filed 2022-11-14 | $70.95K 10-Q · filed 2022-11-14 | $98.13K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $24.79K 10-Q · filed 2022-08-11 | $48.76K 10-Q · filed 2022-08-11 | $75.93K derived: sum of 3 quarters · filed 2022-08-11 | $99.06K derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $23.97K 10-Q · filed 2022-05-12 | $51.14K derived: sum of 2 quarters · filed 2022-05-12 | $74.27K derived: sum of 3 quarters · filed 2022-05-12 | $96.53K derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $27.17K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $50.30K derived: sum of 2 quarters · filed 2022-03-30 | $72.56K derived: sum of 3 quarters · filed 2022-03-30 | $96.55K 10-K · filed 2022-03-30 | |||
| 2020-09-30 | $23.13K 10-Q · filed 2021-11-12 | $45.39K derived: sum of 2 quarters · filed 2021-11-12 | $69.38K 10-Q · filed 2021-11-12 | $91.12K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $22.27K 10-Q · filed 2021-08-13 | $44.49K 10-Q · filed 2021-08-13 | $68.00K derived: sum of 3 quarters · filed 2021-08-13 | $88.34K derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $22.23K 10-Q · filed 2021-05-14 | $45.73K derived: sum of 2 quarters · filed 2021-05-14 | $66.08K derived: sum of 3 quarters · filed 2021-05-14 | $89.19K derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $23.50K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $43.85K derived: sum of 2 quarters · filed 2021-03-26 | $66.96K derived: sum of 3 quarters · filed 2021-03-26 | $90.31K 10-K · filed 2021-03-26 | |||
| 2019-09-30 | $20.35K 10-Q · filed 2020-11-13 | $43.46K derived: sum of 2 quarters · filed 2020-11-13 | $66.80K 10-Q · filed 2020-11-13 | ||||
| 2019-06-30 | $23.11K 10-Q · filed 2020-08-13 | $46.45K 10-Q · filed 2019-08-14 | |||||
| 2019-03-31 | $23.35K 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |